Versant Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.85K | Buy |
+108
| New | +$1.85K | ﹤0.01% | 2399 |
|
|
2025
Q1 | – | Sell |
-23
| Closed | -$2.8K | – | 2616 |
|
|
2024
Q4 | $2.8K | Sell |
23
-25
| -52% | -$3.04K | ﹤0.01% | 1974 |
|
|
2024
Q3 | $6K | Sell |
48
-15
| -24% | -$1.87K | ﹤0.01% | 1232 |
|
|
2024
Q2 | $9.95K | Buy |
+63
| New | +$9.95K | ﹤0.01% | 994 |
|
|
2023
Q3 | – | Sell |
-1
| Closed | -$115 | – | 2047 |
|
|
2023
Q2 | $115 | Buy |
+1
| New | +$115 | ﹤0.01% | 2027 |
|
|
2022
Q1 | – | Sell |
-7
| Closed | -$1K | – | 1618 |
|
|
2021
Q4 | $1K | Sell |
7
-4
| -36% | -$571 | ﹤0.01% | 1349 |
|
|
2021
Q3 | $1K | Sell |
11
-35
| -76% | -$3.18K | ﹤0.01% | 1369 |
|
|
2021
Q2 | $4K | Buy |
46
+37
| +411% | +$3.22K | ﹤0.01% | 983 |
|
|
2021
Q1 | $1K | Buy |
+9
| New | +$1K | ﹤0.01% | 1435 |
|